 | Up a level |
2021
Knispel, Sarah, Gassenmaier, Maximilian, Menzies, Alexander M., Loquai, Carmen, Johnson, Douglas B., Franklin, Cindy 
ORCID: 0000-0001-9142-5423, Gutzmer, Ralf, Hassel, Jessica C., Weishaupt, Carsten, Eigentler, Thomas, Schilling, Bastian, Schummer, Patrick, Sirokay, Judith ORCID: 0000-0003-3945-845X, Kiecker, Felix, Owen, Carina N., Fleischer, Maria, I, Cann, Christopher, Kaehler, Katharina C., Mohr, Peter, Bluhm, Leonie, Niebel, Dennis ORCID: 0000-0003-2069-0486, Thoms, Kai-Martin, Goldinger, Simone M., Reinhardt, Lydia, Meier, Friedegund, Berking, Carola, Reinhard, Raphael, Susok, Laura, Ascierto, Paolo A., Drexler, Konstantin, Pfoehler, Claudia, Tietze, Julia, Heinzerling, Lucie, Livingstone, Elisabeth, Ugurel, Selma, Long, Georgina, V, Stang, Andreas, Schadendorf, Dirk and Zimmer, Lisa ORCID: 0000-0002-3680-3521
(2021).
Outcome of melanoma patients with elevated LDH treated with first-line targeted therapy or PD-1-based immune checkpoint inhibition.
Eur. J. Cancer, 148.
S. 61 - 76.
OXFORD:
ELSEVIER SCI LTD.
ISSN 1879-0852
2016
Hassel, Jessica Cecile, Forschner, Andrea, Blum, Leonie, Heinzerling, Lucie, Zimmer, Lisa, Utikal, Jochen, Kahler, Katharina C., Schlaak, Max, Loquai, Carmen, Gutzmer, Ralf, Kiecker, Felix, Berking, Carola, Bender, Armin, Schneider, Lars, Enk, Alexander, Garbe, Claus, Weichenthal, Michael, Schadendorf, Dirk, Hauschild, Axel and Mohr, Peter (2016). Outcome on 560 metastatic melanoma (MM) patients treated with pembrolizumab during the German Expanded Access Program (EAP). J. Clin. Oncol., 34 (15). ALEXANDRIA: AMER SOC CLINICAL ONCOLOGY. ISSN 1527-7755